Technical Analysis for BLU - BELLUS Health Inc.

Grade Last Price % Change Price Change
grade B 14.12 0.14% 0.020
BLU closed down 1.61 percent on Wednesday, June 3, 2020, on 51 percent of normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Down
Historical BLU trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.14%
Down 3 Days in a Row Weakness 0.14%
20 DMA Resistance Bearish -1.47%
50 DMA Support Bullish -1.47%
BB Squeeze Ended Range Expansion -1.47%
Fell Below 20 DMA Bearish -2.89%
50 DMA Support Bullish -2.89%
Bollinger Band Squeeze Range Contraction -2.89%
BB Squeeze Started Range Contraction -2.89%
Crossed Above 20 DMA Bullish -3.49%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

BELLUS Health Inc. is a drug development company focused on rare diseases. The business activities of the Company are development of the Company's core technology platform, amyloid inhibitors, which focus on chemical compounds that could have the potential to inhibit the formation, deposition and toxicity of amyloid fibrils, which are the underlying causes of certain diseases. The Company operates in the business segment of development of drugs for health solutions. It is focused on developing drugs for rare diseases, starting with conditions that affect the kidneys. Its pipeline of rare disease projects includes KIACTA in Phase III for Amyloid A (AA) amyloidosis; KIACTA for sarcoidosis; clinical stage Shigamab for Hemolytic Uremic Syndrome caused by Shiga toxin-producing E. coli (sHUS), and a research-stage project for amyloid light-chain (AL) amyloidosis. It is partnered with global private equity firm Auven Therapeutics for the development of KIACTA.
Medical Specialties RTT Biology Drug Development Chemical Compounds Amyloid Amyloidosis

Is BLU a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.68
52 Week Low 1.53
Average Volume 116,873
200-Day Moving Average 11.148
50-Day Moving Average 14.077
20-Day Moving Average 14.580
10-Day Moving Average 14.418
Average True Range 0.824
ADX 19.15
+DI 20.776
-DI 15.030
Chandelier Exit (Long, 3 ATRs ) 14.199
Chandelier Exit (Short, 3 ATRs ) 15.841
Upper Bollinger Band 15.351
Lower Bollinger Band 13.808
Percent B (%b) 0.19
BandWidth 10.582
MACD Line 0.138
MACD Signal Line 0.233
MACD Histogram -0.0956
Fundamentals Value
Market Cap 942.78 Million
Num Shares 66.9 Million
EPS 0.00
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 37.49
Price-to-Book 2.65
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.880
Resistance 3 (R3) 14.883 14.627 14.750
Resistance 2 (R2) 14.627 14.428 14.625 14.707
Resistance 1 (R1) 14.363 14.305 14.235 14.360 14.663
Pivot Point 14.107 14.107 14.043 14.105 14.107
Support 1 (S1) 13.843 13.908 13.715 13.840 13.537
Support 2 (S2) 13.587 13.785 13.585 13.493
Support 3 (S3) 13.323 13.587 13.450
Support 4 (S4) 13.320